Innovative Research to Support the Psychological and Emotional Needs of People with Diabetes
ADA Behavioral & Mental Health in Diabetes Research Awards RFA
ADA is soliciting proposals for interventional, generalizable and scalable research to better understand and address how to improve all aspects of the integration of mental health care into clinical settings serving people with diabetes, especially for disadvantaged lower socioeconomic level families where health disparities are most evident. This call is focused on translational research to more effectively deliver personalized, patient-centered psychological and emotional care that considers the context of the person with diabetes, as well as their individual values and preferences.
IMPORTANT TIMELINES
|
AWARD TYPE |
OPEN DATE |
SUBMISSION DEADLINE |
EARLIEST AWARD START DATE |
|---|---|---|---|
|
DEVELOPMENT |
|||
|
Junior Faculty |
- Letter of Interest (LOI): October 3, 2023 - Invitation to Apply from ADA: December 20, 2023 |
- LOI: November 30, 2023 - Application: February 1, 2024 |
July 1, 2024 |
|
RESEARCH |
|||
|
Innovative Clinical or Translational Science |
- Letter of Interest (LOI): October 3, 2023 - Invitation to Apply from ADA: December 20, 2023 |
- LOI: November 30, 2023 - Application: February 1, 2024 |
July 1, 2024 |
Development Awards
Award Summary
Description: These awards support early investigators as they establish independence as diabetes researchers. Refer to the RFA for further details.
Award Term: Up to 3 years
Applicant: Any level faculty up to & including Assistant Prof or equivalent, ≤10 years research experience beyond terminal degree
Maximum Funding: $138,000/year, plus optional student loan repayment ($10K/year)
Support: Project support & PI salary up to $75K (excluding fringe)
Indirect Support: Up to 10% of directs
Citizenship: Authorized to work in U.S. or U.S. possessions
Deadline: NOVEMBER 30, 2023
LOI Materials:
Research Awards
Award Summary
Description: These awards support research with novel and innovative hypotheses, performed in human subjects, or research approaches to accelerate the transition of scientific discoveries into clinical application. Studies supported with these awards must directly involve human subjects, human samples and/or data, and offer considerable promise for advancing the cure, prevention or treatment. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources. Refer to the RFA for further details.
Award Term: Up to 3 years
Applicant: Any level faculty
Maximum Funding: $200,000/year
Support: Project support and PI salary up to 20% of total costs
Indirect Support: Up to 10% of directs
Citizenship: Authorized to work in U.S. or U.S. possessions
Deadline: NOVEMBER 30, 2023
LOI Materials:
Other Forms
Questions?
Please contact Research Programs staff at grantquestions@diabetes.org.